New paradigms in translational science research in cancer biomarkers
about
Current advances in biomarkers for targeted therapy in triple-negative breast cancerSemi-automated literature mining to identify putative biomarkers of disease from multiple biofluids.Current advances in T-cell-based cancer immunotherapyBiomarkers: hopes and challenges in the path from discovery to clinical practice.Review: in vivo optical spectral tissue sensing-how to go from research to routine clinical application?Development and promotion in translational medicine: perspectives from 2012 sino-american symposium on clinical and translational medicine.Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations.Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer.From drug discovery to biomarker-driven clinical trials in lymphomaColorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelledBiomarker discovery and validation: the tide is turning.Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies.Selective mitochondrial staining with small fluorescent probes: importance, design, synthesis, challenges and trends for new markers
P2860
Q28074202-FCAF232A-D335-4860-B054-21CDA76971FFQ34431532-ADA9F8AD-FD87-4EED-A675-E73F0FC55BA9Q35215158-2C018353-00DE-48C2-BDCF-0B61539857C9Q35471494-6A205F32-C19A-419E-85C5-907E40A95A6BQ36210945-F12687A9-03D7-47CF-BF88-BA2AA7D52F2EQ36578313-AEA034BF-39DA-47F8-8F79-732992754F0EQ36594111-D93DDF12-9478-4E49-B9AA-ABA8FE569DB4Q36860418-974B41C2-5365-4224-A201-693752EAF087Q36934087-4C1A4C35-8823-46C4-81BD-A8D86113D27AQ37213965-2D4CC1C8-3CC6-4331-8AEE-D23E7ACEBE4DQ37551148-75957230-0CBD-47F2-ADEF-B67B26F7FE74Q37578725-45107B36-7E33-467C-A0DB-6A0F57622B5DQ43608679-E177617A-9F32-4759-8C24-8FFE9E897D7DQ51676814-6605D98A-9F86-4816-816A-997C370CDD0BQ58337810-28D08EBF-75A4-4E87-8BA9-21F6532E7FE2
P2860
New paradigms in translational science research in cancer biomarkers
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
New paradigms in translational science research in cancer biomarkers
@ast
New paradigms in translational science research in cancer biomarkers
@en
New paradigms in translational science research in cancer biomarkers
@nl
type
label
New paradigms in translational science research in cancer biomarkers
@ast
New paradigms in translational science research in cancer biomarkers
@en
New paradigms in translational science research in cancer biomarkers
@nl
prefLabel
New paradigms in translational science research in cancer biomarkers
@ast
New paradigms in translational science research in cancer biomarkers
@en
New paradigms in translational science research in cancer biomarkers
@nl
P2860
P3181
P1476
New paradigms in translational science research in cancer biomarkers
@en
P2093
Paul D. Wagner
Sudhir Srivastava
P2860
P304
P3181
P356
10.1016/J.TRSL.2012.01.015
P407
P577
2012-04-01T00:00:00Z